Elgethun Capital Management Grows Position in UnitedHealth Group Incorporated (NYSE:UNH)

Elgethun Capital Management boosted its position in UnitedHealth Group Incorporated (NYSE:UNH) by 0.9% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 7,080 shares of the healthcare conglomerate’s stock after purchasing an additional 60 shares during the quarter. Elgethun Capital Management’s holdings in UnitedHealth Group were worth $3,582,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds also recently modified their holdings of the company. Blue Whale Capital LLP acquired a new stake in shares of UnitedHealth Group during the fourth quarter worth $38,522,000. Rathbones Group PLC increased its stake in shares of UnitedHealth Group by 31.1% during the 4th quarter. Rathbones Group PLC now owns 237,395 shares of the healthcare conglomerate’s stock valued at $120,089,000 after acquiring an additional 56,288 shares during the last quarter. U S Wealth Group LLC. purchased a new stake in UnitedHealth Group in the fourth quarter valued at approximately $2,071,000. Twin Capital Management Inc. raised its stake in UnitedHealth Group by 9.3% during the fourth quarter. Twin Capital Management Inc. now owns 18,964 shares of the healthcare conglomerate’s stock worth $9,593,000 after purchasing an additional 1,621 shares during the period. Finally, Employees Retirement System of Texas raised its position in shares of UnitedHealth Group by 760.2% in the 4th quarter. Employees Retirement System of Texas now owns 238,512 shares of the healthcare conglomerate’s stock worth $120,654,000 after buying an additional 210,786 shares during the period. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Price Performance

UnitedHealth Group stock opened at $524.94 on Monday. The stock has a market cap of $480.17 billion, a price-to-earnings ratio of 33.87, a P/E/G ratio of 1.37 and a beta of 0.61. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The business’s 50-day simple moving average is $509.24 and its 200 day simple moving average is $541.85.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. During the same period in the previous year, the firm posted $5.83 earnings per share. UnitedHealth Group’s revenue for the quarter was up 6.8% compared to the same quarter last year. As a group, research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were paid a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a yield of 1.60%. UnitedHealth Group’s payout ratio is 54.19%.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn acquired 1,000 shares of the stock in a transaction dated Friday, January 17th. The shares were bought at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the acquisition, the director now directly owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 0.33% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts recently commented on the stock. HSBC upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price target on the stock in a report on Friday, January 10th. Hsbc Global Res raised UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research report on Friday, January 10th. KeyCorp reaffirmed an “overweight” rating and issued a $650.00 target price on shares of UnitedHealth Group in a research report on Friday, January 17th. Barclays reduced their price target on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a research report on Friday, January 17th. Finally, Piper Sandler lowered their target price on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a research note on Thursday, January 2nd. Twenty equities research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat, UnitedHealth Group presently has a consensus rating of “Buy” and an average price target of $629.32.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.